Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Priming primary care providers to engage in evidence-based discussions about cannabis with patients.

Kansagara D, Becker WC, Ayers C, Tetrault JM.

Addict Sci Clin Pract. 2019 Dec 2;14(1):42. doi: 10.1186/s13722-019-0171-3. Review.

2.

Patients With Opioid Use Disorder Deserve Trained Providers.

Weimer MB, Tetrault JM, Fiellin DA.

Ann Intern Med. 2019 Nov 26. doi: 10.7326/M19-2303. [Epub ahead of print] No abstract available.

PMID:
31766053
3.

Substance Use Disorder Education in Medical Schools: A Scoping Review.

Muzyk A, Smothers ZPW, Akrobetu D, Ruiz Veve J, MacEachern M, Tetrault JM, Gruppen L.

Acad Med. 2019 Nov;94(11):1825-1834. doi: 10.1097/ACM.0000000000002883.

PMID:
31663960
4.

Interprofessional Substance Use Disorder Education in Health Professions Education Programs: A Scoping Review.

Muzyk A, Smothers ZPW, Andolsek KM, Bradner M, Bratberg JP, Clark SA, Collins K, Greskovic GA, Gruppen L, MacEachern M, Ramsey SE, Veve JR, Tetrault JM.

Acad Med. 2019 Oct 22. doi: 10.1097/ACM.0000000000003053. [Epub ahead of print]

PMID:
31651435
5.

Corrigendum to "Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder" [Drug Alcohol Depend. 186 (2018) 171-174].

Holt SR, Donroe JH, Cavallo DA, Tetrault JM.

Drug Alcohol Depend. 2019 Dec 1;205:107601. doi: 10.1016/j.drugalcdep.2019.107601. Epub 2019 Oct 5. No abstract available.

PMID:
31593815
6.

Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial.

Krishnan-Sarin S, O'Malley SS, Franco N, Cavallo DA, Tetrault JM, Shi J, Gueorguieva R, Pittman B, Krystal JH.

Neuropsychopharmacology. 2019 Oct 7. doi: 10.1038/s41386-019-0536-z. [Epub ahead of print]

PMID:
31590179
7.

The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving.

de Laat B, Goldberg A, Shi J, Tetrault JM, Nabulsi N, Zheng MQ, Najafzadeh S, Gao H, Kapinos M, Ropchan J, O'Malley SS, Huang Y, Morris ED, Krishnan-Sarin S.

Biol Psychiatry. 2019 Dec 1;86(11):864-871. doi: 10.1016/j.biopsych.2019.05.021. Epub 2019 Jun 8.

8.

Substance Use Disorder Education in Medical Schools: A Scoping Review of the Literature.

Muzyk A, Smothers ZPW, Akrobetu D, Ruiz Veve J, MacEachern M, Tetrault JM, Grupen L.

Acad Med. 2019 Jul 23. doi: 10.1097/ACM.0000000000002883. [Epub ahead of print]

PMID:
31348067
9.

Opioid overdose prevention education for medical students: Adopting harm reduction into mandatory clerkship curricula.

Oldfield BJ, Tetrault JM, Wilkins KM, Edelman EJ, Capurso NA.

Subst Abus. 2019 Jun 18:1-6. doi: 10.1080/08897077.2019.1621241. [Epub ahead of print]

PMID:
31211657
10.

Integration of care for HIV and opioid use disorder.

Oldfield BJ, Muñoz N, McGovern MP, Funaro M, Villanueva M, Tetrault JM, Edelman EJ.

AIDS. 2019 Apr 1;33(5):873-884. doi: 10.1097/QAD.0000000000002125.

PMID:
30882491
11.

A randomized trial of decision support for tobacco dependence treatment in an inpatient electronic medical record: clinical results.

Bernstein SL, Weiss J, DeWitt M, Tetrault JM, Hsiao AL, Dziura J, Sussman S, Miller T, Carpenter K, O'Connor P, Toll B.

Implement Sci. 2019 Jan 22;14(1):8. doi: 10.1186/s13012-019-0856-8.

12.

"No more falling through the cracks": A qualitative study to inform measurement of integration of care of HIV and opioid use disorder.

Oldfield BJ, Muñoz N, Boshnack N, Leavitt R, McGovern MP, Villanueva M, Tetrault JM, Edelman EJ.

J Subst Abuse Treat. 2019 Feb;97:28-40. doi: 10.1016/j.jsat.2018.11.007. Epub 2018 Nov 20.

PMID:
30577897
13.

La réduction de la consommation de cannabis améliore les résultats fonctionnels au fil du temps.

Deligianni M, Tetrault JM.

Rev Med Suisse. 2018 Nov 28;14(629):2184. French. No abstract available.

PMID:
30484980
14.

Unhealthy Alcohol Use in Primary Care-The Elephant in the Examination Room.

Edelman EJ, Tetrault JM.

JAMA Intern Med. 2019 Jan 1;179(1):9-10. doi: 10.1001/jamainternmed.2018.6125. No abstract available.

PMID:
30422276
15.

Office-Based Addiction Treatment in Primary Care: Approaches That Work.

Edelman EJ, Oldfield BJ, Tetrault JM.

Med Clin North Am. 2018 Jul;102(4):635-652. doi: 10.1016/j.mcna.2018.02.007. Review.

PMID:
29933820
16.

The Changing Face of HIV Care: Expanding HIV Training in an Internal Medicine Residency Program.

Barakat LA, Dunne DW, Tetrault JM, Soares S, Chia D, Ogbuagu OE, Moriarty JP, Huot SJ, Green ML.

Acad Med. 2018 Nov;93(11):1673-1678. doi: 10.1097/ACM.0000000000002317.

PMID:
29901657
17.

Pilot investigation of the effect of carvedilol on stress-precipitated smoking-lapse behavior.

Verplaetse TL, Weinberger AH, Ashare RL, Pittman BP, Shi JM, Tetrault JM, Lavery M, McKee SA.

J Psychopharmacol. 2018 Sep;32(9):1003-1009. doi: 10.1177/0269881118767647. Epub 2018 Apr 25.

18.

Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder.

Holt SR, Donroe JH, Cavallo DA, Tetrault JM.

Drug Alcohol Depend. 2018 May 1;186:171-174. doi: 10.1016/j.drugalcdep.2017.12.040. Epub 2018 Mar 2. Erratum in: Drug Alcohol Depend. 2019 Oct 5;205:107601.

PMID:
29579725
19.

Narrowing the treatment gap in managing opioid use disorder.

Donroe JH, Tetrault JM.

CMAJ. 2018 Mar 5;190(9):E236-E237. doi: 10.1503/cmaj.180209. No abstract available.

20.

Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.

Roberts W, Shi JM, Tetrault JM, McKee SA.

J Addict Med. 2018 May/Jun;12(3):227-233. doi: 10.1097/ADM.0000000000000392.

21.

More Beds or More Chairs? Using a Science-Based Approach to Address the Opioid Epidemic.

Tetrault JM, Fiellin DA.

Ann Intern Med. 2018 Jan 2;168(1):73-74. doi: 10.7326/M17-2854. Epub 2017 Nov 21. No abstract available.

PMID:
29159399
22.

Interpreting quantitative urine buprenorphine and norbuprenorphine levels in office-based clinical practice.

Donroe JH, Holt SR, O'Connor PG, Sukumar N, Tetrault JM.

Drug Alcohol Depend. 2017 Nov 1;180:46-51. doi: 10.1016/j.drugalcdep.2017.07.040. Epub 2017 Aug 24.

PMID:
28866369
23.

Partnering with Psychiatry to Close the Education Gap: An Approach to the Addiction Epidemic.

Tetrault JM, Petrakis IL.

J Gen Intern Med. 2017 Dec;32(12):1387-1389. doi: 10.1007/s11606-017-4140-9. Epub 2017 Aug 1.

24.

Substance Use, Intoxication, and Withdrawal in the Critical Care Setting.

Donroe JH, Tetrault JM.

Crit Care Clin. 2017 Jul;33(3):543-558. doi: 10.1016/j.ccc.2017.03.003. Epub 2017 Apr 20. Review.

PMID:
28601134
25.

The Addiction Recovery Clinic: A Novel, Primary-Care-Based Approach to Teaching Addiction Medicine.

Holt SR, Segar N, Cavallo DA, Tetrault JM.

Acad Med. 2017 May;92(5):680-683. doi: 10.1097/ACM.0000000000001480.

PMID:
28441678
26.

Effect of doxazosin on stress reactivity and the ability to resist smoking.

Verplaetse TL, Weinberger AH, Oberleitner LM, Smith KM, Pittman BP, Shi JM, Tetrault JM, Lavery ME, Picciotto MR, McKee SA.

J Psychopharmacol. 2017 Jul;31(7):830-840. doi: 10.1177/0269881117699603. Epub 2017 Apr 25.

27.

Recognizing and Caring for the Intoxicated Patient in an Outpatient Clinic.

Donroe JH, Tetrault JM.

Med Clin North Am. 2017 May;101(3):573-586. doi: 10.1016/j.mcna.2016.12.012. Review.

PMID:
28372714
28.

Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program.

Butner JL, Gupta N, Fabian C, Henry S, Shi JM, Tetrault JM.

J Subst Abuse Treat. 2017 Apr;75:49-53. doi: 10.1016/j.jsat.2016.12.014. Epub 2017 Jan 24.

PMID:
28237054
29.

Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O.

AIDS Behav. 2017 Apr;21(4):1025-1033. doi: 10.1007/s10461-016-1612-6.

30.

A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.

Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, Patel VV, Phillips KA, Tetrault JM, Shah M, Edelman EJ.

J Gen Intern Med. 2017 Jan;32(1):62-70. doi: 10.1007/s11606-016-3903-z. Epub 2016 Oct 24.

31.

Caring for patients with opioid use disorder in the hospital.

Donroe JH, Holt SR, Tetrault JM.

CMAJ. 2016 Dec 6;188(17-18):1232-1239. doi: 10.1503/cmaj.160290. Epub 2016 Sep 19. Review. No abstract available.

32.

Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.

Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V 3rd, Lim JK, Rimland D, Goulet J, Crystal S, Gaither JR, Gibert CL, Rodriguez-Barradas MC, Fiellin LE, Bryant K, Justice AC, Fiellin DA.

J Subst Abuse Treat. 2016 Sep;68:62-7. doi: 10.1016/j.jsat.2016.06.002. Epub 2016 Jun 6.

33.

Effect of Varenicline Combined with High-Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings.

Verplaetse TL, Pittman BP, Shi JM, Tetrault JM, Coppola S, McKee SA.

Alcohol Clin Exp Res. 2016 Jul;40(7):1567-76. doi: 10.1111/acer.13110. Epub 2016 Jun 1.

34.

Medical Marijuana in Patients Prescribed Opioids: A Cloud of Uncertainty.

Becker WC, Tetrault JM.

Mayo Clin Proc. 2016 Jul;91(7):830-2. doi: 10.1016/j.mayocp.2016.04.008. Epub 2016 May 24. No abstract available.

PMID:
27234481
35.

Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders.

Verplaetse TL, Pittman BP, Shi JM, Tetrault JM, Coppola S, McKee SA.

J Addict Med. 2016 May-Jun;10(3):166-73. doi: 10.1097/ADM.0000000000000208.

36.

Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review.

Tetrault JM, Butner JL.

Yale J Biol Med. 2015 Sep 3;88(3):227-33. eCollection 2015 Sep. Review.

37.

The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection.

Tetrault JM, McCance-Katz EF, Moody DE, Fiellin DA, Lruie BS, DInh AT, Fiellin LE.

J Subst Abuse Treat. 2015 Apr;51:70-4. doi: 10.1016/j.jsat.2014.10.010. Epub 2014 Nov 5.

PMID:
25480096
38.

[Varenicline, an optional treatment for alcohol dependence syndrome in smokers or non-smokers].

Ebert S, Tetrault JM.

Rev Med Suisse. 2014 Oct 8;10(445):1893. French. No abstract available.

PMID:
25417365
39.

Substance use in older HIV-infected patients.

Edelman EJ, Tetrault JM, Fiellin DA.

Curr Opin HIV AIDS. 2014 Jul;9(4):317-24. doi: 10.1097/COH.0000000000000069. Review.

40.

2013 Update in addiction medicine for the generalist.

Gordon AJ, Bertholet N, McNeely J, Starrels JL, Tetrault JM, Walley AY.

Addict Sci Clin Pract. 2013 Nov 4;8:18. doi: 10.1186/1940-0640-8-18. Review.

41.

Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S.

Becker WC, Meghani S, Tetrault JM, Fiellin DA.

Am J Addict. 2014 Jul-Aug;23(4):357-62. doi: 10.1111/j.1521-0391.2013.12109.x. Epub 2013 Sep 24.

PMID:
24112118
42.

2012 Update in addiction medicine for the generalist.

Rastegar DA, Kunins HV, Tetrault JM, Walley AY, Gordon AJ; US Society of General Internal Medicine's Substance Abuse Interest Group.

Addict Sci Clin Pract. 2013 Mar 13;8:6. doi: 10.1186/1940-0640-8-6. Review.

43.

Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.

Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA.

J Addict Med. 2013 Mar-Apr;7(2):102-7. doi: 10.1097/ADM.0b013e31827f9bdf.

44.

Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults.

Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, Hoff RA.

J Adolesc Health. 2013 Feb;52(2):158-63. doi: 10.1016/j.jadohealth.2012.06.010. Epub 2012 Aug 20.

45.

Integration of substance use treatment and medical care: a special issue of JSAT.

Walley AY, Tetrault JM, Friedmann PD.

J Subst Abuse Treat. 2012 Dec;43(4):377-81. doi: 10.1016/j.jsat.2012.09.002. Epub 2012 Oct 15. No abstract available.

PMID:
23079197
46.

Physician detection of unhealthy substance use on inpatient teaching and hospitalist medical services.

Holt SR, Ramos J, Harma M, Cabrera F, Louis-Ashby C, Dinh A, Fiellin DA, Tetrault JM.

Am J Drug Alcohol Abuse. 2013 Mar;39(2):121-9. doi: 10.3109/00952990.2012.715703. Epub 2012 Sep 19.

PMID:
22992028
47.

Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients.

Tetrault JM, Moore BA, Barry DT, O'Connor PG, Schottenfeld R, Fiellin DA, Fiellin LE.

J Subst Abuse Treat. 2012 Dec;43(4):433-9. doi: 10.1016/j.jsat.2012.07.011. Epub 2012 Aug 29.

PMID:
22938914
48.

Combining rapid HIV testing and a brief alcohol intervention in young unhealthy drinkers in the emergency department: a pilot study.

Edelman EJ, Dinh A, Radulescu R, Lurie B, D'Onofrio G, Tetrault JM, Fiellin DA, Fiellin LE.

Am J Drug Alcohol Abuse. 2012 Nov;38(6):539-43. doi: 10.3109/00952990.2012.701359. Epub 2012 Jul 16.

49.

Developing and implementing a multispecialty graduate medical education curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT).

Tetrault JM, Green ML, Martino S, Thung SF, Degutis LC, Ryan SA, Martel S, Pantalon MV, Bernstein SL, O'Connor PG, Fiellin DA, D'Onofrio G.

Subst Abus. 2012;33(2):168-81. doi: 10.1080/08897077.2011.640220.

PMID:
22489589
50.

Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education.

Holt SR, Ramos J, Harma MA, Cabrera F, Louis-Ashby C, Dinh A, Tetrault JM, Fiellin DA.

Am J Addict. 2012 Mar-Apr;21(2):111-9. doi: 10.1111/j.1521-0391.2011.00207.x. Epub 2012 Feb 7.

PMID:
22332853

Supplemental Content

Loading ...
Support Center